A detailed history of Holderness Investments CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Holderness Investments CO holds 1,246 shares of VRTX stock, worth $561,161. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,246
Previous 1,266 1.58%
Holding current value
$561,161
Previous $593,000 2.36%
% of portfolio
0.13%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$460.0 - $505.78 $9,200 - $10,115
-20 Reduced 1.58%
1,246 $579,000
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $51,065 - $63,118
130 Added 11.44%
1,266 $593,000
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $52,999 - $57,990
130 Added 12.92%
1,136 $474,000
Q3 2023

Nov 15, 2023

BUY
$338.18 - $362.46 $15,218 - $16,310
45 Added 4.68%
1,006 $349,000
Q2 2023

Aug 15, 2023

BUY
$314.42 - $351.91 $302,157 - $338,185
961 New
961 $338,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Holderness Investments CO Portfolio

Follow Holderness Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holderness Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Holderness Investments CO with notifications on news.